Our animal and cellular experiments revealed that ITGB8 expression is downregulated in DN patients, and that NGR1 can upregulate ITGB8 expression, potentially mitigating inflammatory injury in podocytes. This evidence concerns the gene ITGB8 and liver dysplastic nodule.